Department of Surgical Oncology, The University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199, USA.
J Palliat Med. 2011 Sep;14(9):990-6. doi: 10.1089/jpm.2011.0083. Epub 2011 Jul 18.
The purpose of this study was to identify preoperative clinical and radiographic factors relevant to treatment selection and outcomes in patients with advanced cancer presenting with bowel obstruction.
Clinical and radiographic data were retrospectively obtained from records of inpatients with suspected bowel obstruction referred for palliative surgical consultation (2000-2006). Patients were stratified according to site of obstruction: gastric outlet obstruction (GOO), small bowel obstruction (SBO), and large bowel obstruction (LBO). We utilized the Cox proportional hazards model to identify preoperative clinical and radiologic variables associated with overall survival (OS).
Of 191 patients, the site of obstruction was classified as GOO in 41 (21%), SBO in 122 (64%), and LBO in 28 (15%). Almost half of the patients (47%) had received systemic therapy in the 6 weeks prior to evaluation. The most common sites of disease identified on imaging included abdominal visceral metastases (37%), carcinomatosis/sarcomatosis (46%), and an intact primary tumor or recurrence (31%). Most patients (62%) exhibited 2 or more sites of disease on imaging. Treatment strategies included nonoperative/nonprocedural management in 41% (n = 79), endoscopic/interventional radiology procedures in 25% (n = 48), and surgery in 34% (n = 64). Median OS for the cohort was 3.5 months (95% confidence interval [CI]: 2.7-4.6). Median OS for GOO, SBO, and LBO was 2.7 (95% CI: 1.7-4.1), 3.5 (95% CI: 2.5-4.9), and 7.0 (95% CI: 2.1-11) months, respectively (p = 0.17). Adverse prognostic factors for OS included endoscopic/interventional radiology procedures and ≥3 radiologically evident sites of disease.
OS, although low, was not significantly different among GOO, SBO, and LBO. Single sites of disease identified on imaging were not associated with OS, although multiple sites of disease were associated with diminished OS.
本研究旨在确定与晚期癌症伴肠梗阻患者的治疗选择和结局相关的术前临床和影像学因素。
回顾性获取 2000 年至 2006 年间因疑似肠梗阻而行姑息性外科会诊的住院患者的临床和影像学资料。根据梗阻部位将患者分层:胃出口梗阻(GOO)、小肠梗阻(SBO)和大肠梗阻(LBO)。我们利用 Cox 比例风险模型确定与总生存期(OS)相关的术前临床和影像学变量。
在 191 名患者中,梗阻部位分类为 GOO 者 41 例(21%)、SBO 者 122 例(64%)、LBO 者 28 例(15%)。近一半的患者(47%)在评估前 6 周内接受了全身治疗。影像学上最常见的疾病部位包括腹部内脏转移(37%)、癌性腹膜炎/肉瘤病(46%)和完整的原发肿瘤或复发(31%)。大多数患者(62%)在影像学上有 2 个或更多的疾病部位。治疗策略包括非手术/非介入性管理 41%(n=79)、内镜/介入放射学治疗 25%(n=48)和手术 34%(n=64)。该队列的中位 OS 为 3.5 个月(95%置信区间[CI]:2.7-4.6)。GOO、SBO 和 LBO 的中位 OS 分别为 2.7(95% CI:1.7-4.1)、3.5(95% CI:2.5-4.9)和 7.0(95% CI:2.1-11)个月(p=0.17)。OS 的不良预后因素包括内镜/介入放射学治疗和≥3 个影像学可见的疾病部位。
尽管 OS 较低,但 GOO、SBO 和 LBO 之间并无显著差异。尽管影像学上存在多个疾病部位与 OS 降低相关,但单一疾病部位与 OS 无关。